Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
PMID 12235537
Other information about the product is contained in the safety data sheet, which we make available for inspection
Potential mild effects observed in animal and in vitro models include transient fatigue, mild nausea, or digestive discomfort related to metabolic acceleration
It is a professionally compounded prescription peptide blend intended for use under the guidance of a licensed healthcare provider
Dual-peptide formulation for synergistic research applications BPC-157: studied for tissue-protective and cytoprotective signalling pathways TB-500: investigated for roles in cell migration and angiogenesis Flexible volume delivery with four increment options Extended stability formulation What Researchers Say Frequently Asked Questions A dual-peptide formulation of BPC-157 (a gastric-juice-derived pentadecapeptide) and TB-500 (synthetic Thymosin Beta-4), both studied in preclinical tissue-repair, angiogenesis, and matrix-remodelling research
, Strinic, D
